Feb 06, 2017 14:26 pm UTC| Business
Press release - No. 1/2017 Patient recruitment completed for phase II trial with glepaglutide for treatment of short bowel syndrome Results of the phase II trial are expected mid 2017 Glepaglutide is a novel...
Merit Medical Acquires Products From Argon Medical Devices and Catheter Connections, Inc.
Feb 06, 2017 14:25 pm UTC| Business
SOUTH JORDAN, Utah, Feb. 06, 2017 -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced...
Dan Frink Joins Greystone as a Managing Director to Help Transform FHA Lending Process
Feb 06, 2017 14:15 pm UTC| Business
NEW YORK, Feb. 06, 2017 -- Greystone, a real estate lending, investment and advisory company, today announced Dan Frink has been appointed as a Managing Director, taking on a senior position on the FHA lending team. ...
Reata Scheduled to Attend Upcoming Investor Conferences
Feb 06, 2017 14:15 pm UTC| Business
IRVING, Texas, Feb. 06, 2017 -- Reata Pharmaceuticals, Inc.(NASDAQ:RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for patients with serious or...
Feb 06, 2017 14:13 pm UTC| Business
NEW YORK, Feb. 06, 2017 -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Stemline Therapeutics, Inc. (“Stemline”)...
Feb 06, 2017 14:07 pm UTC| Business
ATLANTA, Feb. 06, 2017 -- Atlanta-based SouthCrest Bank(SCSG:PK), a leading provider of funding for film productions under the Georgia Entertainment Industry Investment Act, is urging the business community to support...
Willis Towers Watson publishes its fourth Older Age Mortality Study for U.S. life insurers
Feb 06, 2017 14:05 pm UTC| Business
ARLINGTON, Va., Feb. 06, 2017 -- Willis Towers Watson (NASDAQ:WLTW), a leading global advisory, broking and solutions company, today announced the release ofThe Older Age Mortality Study 4 (TOAMS 4), the company's...